Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Conditions:  Adult Alveolar Soft Part Sarcoma;  Adult Angiosarcoma;  Adult Desmoplastic Small Round Cell Tumor;  Adult Epithelioid Hemangioendothelioma;  Adult Epithelioid Sarcoma;  Adult Extraskeletal Myxoid Chondrosarcoma;  Adult Extraskeletal Osteosarcoma;  Adult Fibrosarcoma;  Adult Leiomyosarcoma;  Adult Liposarcoma;  Adult Malignant Mesenchymoma;  Adult Malignant Peripheral Nerve Sheath Tumor;  Adult Rhabdomyosarcoma;  Adult Synovial Sarcoma;  Adult Unclassified Pleomorphic Sarcoma;  Chondrosarcoma;  Clear Cell Sarcoma of the Kidney;  Conjunctival Kaposi Sarcoma;  Dermatofibrosarcoma Protuberans;  Gastrointestinal Stromal Tumor;  Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;  Metastatic Osteosarcoma;  Ovarian Sarcoma;  Recurrent Adult Soft Tissue Sarcoma;  Recurrent Adult Unclassified Pleomorphic Sarcoma of Bone;  Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;  Recurrent Kaposi Sarcoma;  Recurrent Osteosarcoma;  Recurrent Uterine Corpus Sarcoma;  Small Intestine Leiomyosarcoma;  Stage III Adult Soft Tissue Sarcoma;  Stage III Uterine Sarcoma;  Stage IV Adult Soft Tissue Sarcoma;  Stage IV Uterine Sarcoma;  Unclassified Pleomorphic Sarcoma of BoneInterventions:  Drug: Gamma-Secretase Inhibitor RO4929097;  Other: Laboratory Biomarker Analysis;  Other: PharmacologicalÂ...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Angiosarcoma | Bone Cancers | Cancer & Oncology | Chondrosarcoma | Dermatology | Ewing's Sarcoma | Fibrosarcoma | Gastroenterology | Hemangioendothelioma | Leiomyosarcoma | Liposarcoma | Neurology | Osteosarcoma | Research | Rhabdomyosarcoma | Sarcomas | Study | Urology & Nephrology